Controversy

How imaging should adapt to a molecularly-defined tumor taxonomy where histology-era imaging correlates may no longer hold

Evidence grade: WEAK — Supported only by weak or preliminary evidence.

computed from the encoded evidence by the Atlas grading rule.

Position A

WHO CNS5 improves biological precision; imaging phenotypes can be re-mapped to molecular entities

Position B

Much legacy imaging literature is built on histologic grades now reclassified; imaging-outcome correlations need wholesale revalidation under CNS5

Clinical stakes

Entire prior imaging-biomarker evidence base may be partially miscalibrated to obsolete classes

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Reviewed by Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Last updated 2026-07-01.

This is an educational research resource from Resonant Labs, not clinical advice. Evidence grades and controversies are summarized from the literature and may change as the field evolves.